MULTIOMICS INTEGRATION IN ANTI-TUBERCULOSIS DRUG DISCOVERY
Despite intensive global efforts, tuberculosis remains one of the leading global health burdens, with antimicrobial resistance being a significant challenge to managing the disease. In addition, the current drugs used to treat tuberculosis suffer from limitations, such as prolonged therapeutic durat...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Association of medical doctors Sanamed Novi Pazar
2025-05-01
|
| Series: | Sanamed |
| Subjects: | |
| Online Access: | https://new.sanamed.rs/pdf/20_1/20_1_11.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Despite intensive global efforts, tuberculosis remains one of the leading global health burdens, with antimicrobial resistance being a significant challenge to managing the disease. In addition, the current drugs used to treat tuberculosis suffer from limitations, such as prolonged therapeutic duration and toxicity. Therefore, the development of new anti-tuberculosis drugs is a priority. However, this process faces several challenges. The introduction of a multiomics approach could serve as an ideal platform to accelerate drug development by addressing these challenges. This article reviews the potential role of multiomics in anti-tuberculosis drug development and briefly discusses the associated challenges in utilizing multiomics for drug discovery. |
|---|---|
| ISSN: | 1452-662X 2217-8171 |